Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00816387
Other study ID # RU01/07
Secondary ID
Status Completed
Phase N/A
First received December 31, 2008
Last updated December 2, 2010
Start date October 2007
Est. completion date December 2009

Study information

Verified date March 2009
Source IRCCS Burlo Garofolo
Contact n/a
Is FDA regulated No
Health authority Italy: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of fallopian sperm perfusion (FSP) in comparison with standard intrauterine insemination (IUI) in natural cycle for couples with unexplained infertility or mild male factor.


Description:

A number of randomised controlled trials have been published comparing the efficacy of FSP with standard IUI. A recent meta-analysis has suggested that in couples with unexplained infertility Fallopian tube sperm perfusion together with controlled ovarian hyperstimulation (COH) leads to increased pregnancy rates than IUI and COH. No study has been published comparing the two insemination techniques in natural cycle.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date December 2009
Est. primary completion date October 2009
Accepts healthy volunteers No
Gender Female
Age group 24 Years to 40 Years
Eligibility Inclusion Criteria:

- infertility for at least 2 years

- age <40 years

- unexplained infertility or mild male factor

Exclusion Criteria:

- previous assisted reproduction treatment

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Fallopian tube sperm perfusion
Patients are treated with fallopian tube sperm perfusion
Intrauterine insemination using standard catheter
Patients are treated with standard intrauterine insemination

Locations

Country Name City State
Italy IRCCS Burlo Garofolo Trieste

Sponsors (1)

Lead Sponsor Collaborator
IRCCS Burlo Garofolo

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary clinical pregnancy rate 2 years No
Secondary Abortion rate 2 years No
Secondary Ectopic pregnancy rate 2 years Yes
See also
  Status Clinical Trial Phase
Completed NCT03549533 - Impact of Aluminum on Sperm DNA Quality